JP MORGAN/CALL/BECTON DICKINSON AND CO./270/0.1/17.01.25 Stock

Warrant

DE000JL1MHW7

Real-time Bid/Ask 06:39:28 2024-06-14 am EDT
0.89 EUR / 1.04 EUR -8.10% Intraday chart for JP MORGAN/CALL/BECTON DICKINSON AND CO./270/0.1/17.01.25
Current month+25.00%
1 month-21.05%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-14 0.95 -9.52%
24-06-13 1.05 -5.41%
24-06-12 1.11 -15.27%
24-06-11 1.31 0.00%
24-06-10 1.31 +0.77%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 03:20 am EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1MHW
ISINDE000JL1MHW7
Date issued 2023-04-05
Strike 270 $
Maturity 2025-01-17 (218 Days)
Parity 10 : 1
Emission price 2.48
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 5.68
Lowest since issue 0.71
Delta0.33x
Omega 7.249
Premium21x
Gearing21.71x
Moneyness 0.8591
Difference Strike 38.03 $
Difference Strike %+14.09%
Spread 0.2
Spread %18.18%
Theoretical value 0.9900
Implied Volatility 30.36 %
Total Loss Probability 74.51 %
Intrinsic value 0.000000
Present value 0.9900
Break even 280.59 €
Theta-0.03x
Vega0.06x
Rho0.04x

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232 USD
Average target price
278.7 USD
Spread / Average Target
+20.14%
Consensus